Poland's leading research university combining biomedical sciences, advanced spectroscopy, and social science across 69 H2020 projects with 688 partners.
Jagiellonian University in Kraków is Poland's oldest and most prestigious university, with deep research capacity spanning life sciences, physics, social sciences, and humanities. In H2020, they contribute advanced analytical capabilities — from metabolomics and biomarker discovery to zero-field NMR spectroscopy and synchrotron-based techniques — alongside strong social science research on topics like aging, migration, and institutional change. They serve as a training hub through multiple Marie Skłodowska-Curie networks and actively bridge fundamental research with clinical and industrial applications in areas such as drug discovery, personalized medicine, and food sciences.
Projects spanning drug discovery (AEGIS), uveal melanoma therapies (UM Cure 2020), cancer immunotherapy (CANCER), organ-on-chip (CISTEM), lung cancer diagnostics (LungCARD), and clinical trials.
Coordinated zero-field NMR research (ZULF), synchrotron access (CALIPSOplus), quantum simulations (QUIC), and metabolomics across multiple health/food projects.
Research on post-crisis legitimacy (PLATO), ageism (EuroAgeism), gender equality (ACT, GENERA), community policing and refugees (ICT4COP), and Central European political transformation (FATIGUE).
Nutrigenomics and biomarker work in PREVENTOMICS, ecosystem services in EcoStack, sustainable agriculture in SUFISA, and omics-based dietary disease prevention.
Repeated participation in European Researchers' Night (Power2Nights, MalopolskaRN), multiple MSCA training networks (10 MSCA-ITN, 8 MSCA-RISE projects).
Contentious heritage transmission (TRACES), ethics and comparative philosophy appearing in recent keyword clusters, and sustainability-oriented cultural projects.
In the early H2020 period (2014–2018), Jagiellonian focused heavily on public science engagement (Researchers' Night events, laboratory demonstrations, workshops) and foundational research in areas like metabolomics, quantum physics, and epigenetics. From 2019 onward, the portfolio shifted toward applied and translational work — clinical trials, industry partnerships, big data analytics, synchrotron techniques, and knowledge transfer — alongside growing attention to ethics, sustainability, and cultural heritage. This reflects a maturing trajectory from basic science and outreach toward research with direct societal and industrial impact.
Jagiellonian is moving from fundamental research toward industry-relevant applications, clinical translation, and data-intensive methods — making them increasingly valuable as a partner bridging academia and business.
Jagiellonian operates predominantly as a consortium partner (57 of 69 projects), contributing specialized expertise rather than leading large initiatives — though they have coordinated 10 projects, showing they can lead when the topic fits their core strengths. With 688 unique partners across 54 countries, they are a highly connected hub with broad European reach, comfortable operating in large multi-partner consortia typical of MSCA networks and RIA projects. Their wide partner diversity suggests openness to new collaborations rather than reliance on a fixed circle.
Exceptionally well-connected with 688 unique consortium partners spanning 54 countries, placing them among the most networked Polish universities in H2020. Strong ties across Western and Central Europe, with reach extending globally through MSCA mobility networks.
Jagiellonian combines world-class analytical capabilities (zero-field NMR, synchrotron, metabolomics) with unusually strong social science and humanities research — a rare combination that enables genuinely interdisciplinary projects spanning health, food, ethics, and cultural heritage. As Poland's top-ranked university, they bring credibility and access to Central European research ecosystems that Western partners often lack. Their 10 MSCA training networks make them an ideal partner for projects requiring structured doctoral training or researcher mobility components.
